Anika Therapeutics | ANIK - Capitale Sociale E Riserve

Prezzo Delle Azioni
14.69
Cambio Giornaliero
-0.26 -1.74%
Mensile
-1.54%
Annuale
1.38%
Q2 Previsione
14.54




Capitale Sociale E Riserve Cambiamento Data
Abbott USD 52.06B 69M 2026-03
Agenus USD -271.11M 3.03M 2025-12
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Anika Therapeutics USD 133.9M 9.56M 2026-03
Arrowhead Research USD 568.42M 102.37M 2025-12
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Heron Therapeutics USD 13.28M 1.6M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Integra LifeSciences USD 1.04B 1.06M 2026-03
Intrexon USD 43.17M 75.33M 2024-06
J&J USD 81.19B 358M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
Merit Medical Systems USD 1.63B 42.42M 2026-03
Rigel Pharmaceuticals USD 117.61M 35.67M 2025-09
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sanofi EUR 72.81B 1.1B 2026-03
Smith & Nephew USD 5.54B 331M 2025-12
Stryker USD 22.42B 635M 2025-12
Surmodics USD 111.31M 7.59M 2025-06
Veracyte USD 1.34B 34.83M 2026-03
Xencor USD 635.59M 10.27M 2025-12
Zimmer Biomet Holdings USD 12.68B 16.1M 2026-03